Press Releases
Technology focused company streamlines operations while focused on its digital platform
Austin, Texas, June 02, 2024 (GLOBE NEWSWIRE) -- ePac Flexible Packaging, founded in 2016 as the world's first all-digital flexible packaging company, just turned 8 years old in May of this year. So it’s fair to ask: How is ePac doing with its disruptive business model? From 2016 through 2022 ePac consistently grew 50 -100% per year. In 2023 ePac’s growth slowed, but units... (continue reading...)
SAN FRANCISCO and SUZHOU, China, June 2, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology and other major diseases, announced that results from the pivotal Phase 2 TRUST-I study conducted in China evaluating taletrectinib, next-generation ROS1... (continue reading...)
Imagine a world where seeing eyelid surgery results before the surgery are no longer just a dream but a reality. With groundbreaking advancements in technology and 3D facial images, the realm of blepharoplasty is on the brink of a major revolution.
London, United Kingdom Jun 1, 2024 (Issuewire.com) - Ophthalmologist and Oculoplastic Surgeon Mr Ahmad Aziz has come up with a new service through his leading clinic in Central London, known as Eyes Defined. The clinic is... (continue reading...)
SUZHOU, China, and ROCKVILLE, Md., June 1, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that it has released updated data of its novel drug candidate AGP-2449, a FAK/ALK/ROS1 tyrosine kinase inhibitor (TKI), in patients with non-small-cell lung cancer (NSCLC) in a poster presentation at the 60th American Society... (continue reading...)
NEW YORK, June 01, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against Biogen Inc. (“Biogen” or the “Company”) (NASDAQ: BIIB) in the United States District Court for the District of Colorado on behalf of all persons and entities who purchased or otherwise acquired Biogen securities between February 3, 2022 and February 13, 2024, both... (continue reading...)
More Press Releases
View Older Stories-
Jacobio Pharma Presents SHP2 Plus KRAS G12C Data at ASCO
-
OPPO Scores Unforgettable Experiences with Global Brand Ambassador Kaka' at the UEFA Champions League Final 2024
-
CStone Announces European Medicine Agency CHMP Recommends Approval of Cejemly® (sugemalimab, anti-PD-L1) as First-Line Treatment for NSCLC
-
OPPO Scores Unforgettable Experiences with Global Brand Ambassador Kaká at the UEFA Champions League Final 2024
-
Heineken® Celebrates Thousands of ‘Real Hardcore Fans’ by Helping Them Take Part in the UEFA Champions League Final Trophy Celebrations For The First Time Ever
-
Innovent Presents at the 2024 ASCO Annual Meeting on Clinical Data of anti-CLDN18.2 ADC (IBI343) in Patients with Advanced Pancreatic Cancer or Biliary Tract Cancer
-
Innovent Announces Data from Pivotal Phase 2 TRUST-I Study of Taletrectinib(ROS1 Inhibitor) are Published in the JCO and Reported at 2024 ASCO Annual Meeting
-
Innovent Presents Phase 1 Clinical Data of First-in-class PD-1/IL-2α Bispecific Antibody Fusion Protein (IBI363) in Melanoma, Colorectal Cancer and other Solid Tumors at the 2024 ASCO Annual Meeting
-
GenFleet Therapeutics Announces Efficacy & Safety Result from Phase II Trial for First-line NSCLC Treatment in KROCUS Study, fulzerasib (KRAS G12C Inhibitor) in Combination with cetuximab, in a La
-
LENNY KRAVITZ ROCKS OUT AT THE UEFA CHAMPIONS LEAGUE FINAL KICK OFF SHOW PRESENTED BY PEPSI®
-
Sun Bum Makes SPF Waves in Miami with its Largest Ever Beach Hangout for Skin Cancer Awareness Month
-
National Skills Champions are Honoured at the Skills Canada National Competition 2024, in Québec
-
Sapience Therapeutics Presents Positive Clinical and Biomarker Data from ST101 Phase 2 Study in GBM at ASCO 2024 in Oral Presentation
-
BIOHACKING CONFERENCE ANNOUNCES STEMREGENⓇ WILL RETURN AS TITLE SPONSOR FOR 2025
-
First Federal Savings Bank and ICBA Offer Tips to Help Simplify the Homebuying Process
-
Immunofoco Biotech to Unveil Solid Tumor CAR-T Programs Clinical Trial Data at 2024 ASCO Meeting
-
Cantargia ASCO Presentation Highlights Positive Clinical Data on Nadunolimab Counteracting Neuropathy
-
Sun, Sand, and Smooth Skin: Grab Ulike Air 10 for a Summer Beach Adventure
-
New Data Provide Schizophrenia Treatment Insights into Switching to UZEDY® (risperidone) Extended-Release Injectable Suspension from Invega Sustenna® (paliperidone palmitate)
-
Robotbulls - The Future of Cryptocurrency Trading: Integrating AI and Blockchain Data
-
What Custom Stickers Are Best for Glass?
-
Teva Presents First Real-World Data from the IMPACT-TD Registry Study at Psych Congress Elevate 2024
-
Karyopharm Presents Updated Exploratory Subgroup Analyses from SIENDO Study in Patients with Advanced or Recurrent TP53 Wild-Type Endometrial Cancer During 2024 ASCO Plenary Series: Rapid Abstract Upd
-
Thrive with GBA | The Bay to Bay Dialogue held to deepen mutual understanding between China and US
-
All-in-One Job Shop Software for Fabrication Shops by Steelhead Technologies
-
Taseko Announces that Operations at its Gibraltar Mine have been Suspended
-
Affimed Provides Follow-up Data of AFM24 plus Atezolizumab Showing Durable Responses in Heavily Pretreated NSCLC EGFR Wild-type Patients and Positive Initial Data from the NSCLC EGFR Mutant Cohort
-
PHILADELPHIA KICKS OFF PRIDE MONTH BY SETTING THE FIRST-EVER GUINNESS WORLD RECORDS™ FOR THE "LARGEST ATTENDANCE AT DRAG QUEEN STORY TIME"
-
Michael Bernstein Offers Dropshipping Consulting to Help Clients Build Successful, Long-Term Businesses
-
Union members and allies mark Injured Workers’ Day in locations across Ontario
-
Sustainable Tourism Initiative: Responsible Travel Merchandise Store Announced
-
Prospera Energy Inc. Announces 2023 Financial Results
-
FameEX CEO’s Message: Keep the Intention in the Crypto Bull Market for a Better Departure
-
Mr. Business Magazine Spotlights Diana Muniz-Lebrun, Founding Partner and CEO at Olympus Marketing
-
CIO Women Magazine Spotlights Claudia Patricia Eusse, CEO, The Eusse Group, as Influential Women Leaders in Real Estate
-
Z Grills Announces Unprecedented "Buy 1, Get 10 Grills" Promotion, Unlocking a Lifetime of Easier Grilling!
-
WATCH by Aisles: A Revolutionary AI System for Public Safety
-
ICECO Launches APL35 on Indiegogo - The World's Lightest Aluminum Dual-Zone Freezer
-
Gregory P Lee Personal Injury Lawyer The Woodlands Expands Services to Meet Rising Demand in Texas for Personal Injury Cases
-
Innovative Solutions and Cutting-Edge Technologies Take Centre Stage at Water Expo Delhi 2024
-
Revolutionizing Sustainability: The Environment Protection Technologies Expo
-
Goat Token A must have rising star in the crypto world
-
Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-sma
-
Black Diamond Therapeutics Presents Promising BDTX-1535 Clinical Data in Patients with Recurrent Glioblastoma at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
-
"Experience the Luxury of Japanese Tradition and Cuisine" Reservations for the New Inbound Experience Tour in Osaka's Tondabayashi Begin on June 1, 2024!
-
First Ascent Biomedical Presents Findings from Clinical Studies in Pediatric and Adult Cancers Using its AI-Enhanced Functional Precision Medicine Platform at ASCO 2024
-
Tag along with Jason in Zhengzhou: Experiencing Kung Fu at the Shaolin Temple
-
SYS6002 (CRB-701) A Next-Generation Nectin-4 Targeting Antibody Drug Conjugate Continues to Demonstrate Encouraging Safety and Efficacy Observed in Patients with Nectin-4 Positive Tumors in a Clinical
-
Tempus Announces Expansion of Collaboration with AstraZeneca to Leverage Tempus Next to Support Guideline-directed Biomarker Testing in NSCLC
-
Wisconsin Top Performing Stocks